Will Amazon (NASDAQ:AMZN) Get Involved in Cannabis?

Amazon.com, Inc. (NASDAQ:AMZN) is always looking for growth opportunities, and cannabis is one industry that is going to drive a lot of it in the years to come.

| More on:
edit Jars of marijuana

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Over the past few years, there’s been a lot of interest in cannabis from other industries. While most of it has been just tire kicking, there have been a couple of big deals, most notably involving Constellation Brands and Canopy Growth.

However, cannabis isn’t a fit for everyone, at least not while cannabis remains illegal federally. Starbucks suggested that it might not be a good fit for its brand, while Coca-Cola has backed away after rumours swirled that it was looking at partnering with cannabis giant Aurora Cannabis (TSX:ACB)(NYSE:ACB). Most recently, Amazon.com (NASDAQ:AMZN) has been linked to the industry with talks that Whole Foods could start selling cannabis once legal barriers were out of the way.

In a recent interview, Whole Foods CEO John Mackey stated, “If cannabis is ever passed in Texas, chances are good that grocery stores will be selling that too.” Mackey has previously expressed his support for marijuana legalization and so it might not be a big leap for cannabis products to make it onto store shelves at some point. A big reason why that likely won’t be until after cannabis is legalized federally is due to logistics.

While hemp products could be sold in Whole Foods and can be easily transported across state lines now that the farm bill has passed, the same cannot be said for tetrahydrocannabinol products or cannabidiol not derived from hemp. And for parent company Amazon, that’s undoubtedly a big impediment given its focus on efficiency and being able to move products seamlessly.

Amazon site currently sells cannabis-related items

Although we haven’t seen a clear indication of if Amazon would consider selling marijuana once legalization takes place, it’s worth noting that on its U.S. site it is already selling hemp oil along with cannabis cookbooks and apparel as well.

It’s a good example of where actions speak louder than words, and Amazon is clearly not taking a hard stance against cannabis. The company has been ahead of the curve. I’d be surprised if it didn’t keep up with the latest trends and the growing demand for cannabis, especially if it leads to more sales growth.

The big question to me is not whether Amazon will get involved in cannabis, but whether it will seek out to partner or acquire a company in the emerging industry.

Why Aurora could be a good target for Amazon

Aurora Cannabis stands out to me as a great potential fit for the tech giant. Lacking a major partner that could help fund its operations and growth, Aurora could use the cash and would help give Amazon a big presence in the industry almost instantly. And although Aurora doesn’t have a footprint south of the border just yet, that could quickly change with hemp now legalized.

Aurora has generated lots of sales growth in its most recent quarter now that marijuana has been legalized in Canada, and it’s only scratching the surface of what it could do down the road as the industry continues to grow. The potential growth it would have would certainly take off with big funding from a big company like Amazon to help finance it.

However, even if the tech giant was interested, it’ll still likely be years away before marijuana is legalized in the U.S. and before Amazon takes a serious look at the industry.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Fool contributor David Jagielski has no position in any of the stocks mentioned. David Gardner owns shares of Amazon and Starbucks. Tom Gardner owns shares of Starbucks. The Motley Fool owns shares of Amazon and Starbucks. Starbucks is a recommendation of Stock Advisor Canada.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »